{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:45:25Z","timestamp":1783035925516,"version":"3.54.6"},"reference-count":31,"publisher":"The Pediatric Pharmacy Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:p>Sialorrhea, defined as an excess flow of saliva or excessive secretions, is common in patients with cerebral palsy and other neurologic disorders and is associated with clinical complications such as increased risk of local skin reactions, infections, aspiration, pneumonia, and dehydration. Upon failure of non-pharmacologic measures, clinicians have several noninvasive pharmacologic options available to manage sialorrhea. This review of the literature provides detailed descriptions of medications used, efficacy, safety, and practical considerations for use of non-injectable pharmacologic agents. The literature search included published \u00adhuman studies in the English language in PubMed and Google Scholar from 1997 to 2022. Relevant citations within articles were also screened. A total of 15 studies representing 719 pediatric patients were included. Glycopyrrolate, atropine, scopolamine, and trihexyphenidyl all have a potential role for sialorrhea management in children; however, glycopyrrolate remains the most studied option with 374 (n = 52.0%) of the 719 patients included in the systematic review receiving this medication. Overall, glycopyrrolate showed similar efficacy but higher tolerability than its comparators in 2 comparative studies and is often considered the first-line agent. Patient-specific (age, route of administration) and medication-specific (dosage formulation, medication strength) considerations must be weighed when initiating a new therapy or switching to another medication upon treatment failure. Owing to the high propensity of adverse events with all agents, clinicians should consider initiating doses at the lower end of the dosage range, as previous studies have noted a dose-dependent relationship.<\/jats:p>","DOI":"10.5863\/1551-6776-29.1.6","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T12:01:59Z","timestamp":1707739319000},"page":"6-21","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacologic Management of Sialorrhea in Neonatal and Pediatric Patients"],"prefix":"10.5863","volume":"29","author":[{"given":"Caitlyn V.","family":"Bradford","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice (CVB), Philadelphia College of Pharmacy at Saint Joseph\u2019s University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery M.","family":"Parman","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences (AMP, JLM, PNJ), University of Oklahoma College of Pharmacy, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences (AMP, JLM, PNJ), University of Oklahoma College of Pharmacy, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Clinical and Administrative Sciences (AMP, JLM, PNJ), University of Oklahoma College of Pharmacy, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"issue":"1","key":"2024021212015439400_i2331-348X-29-1-6-b01","first-page":"E22","article-title":"Clinical prevalence of drooling in infant cerebral palsy","volume":"13","author":"Morales Chavez","year":"2008","journal-title":"Med Oral Patol Oral Cir Bucal"},{"issue":"6","key":"2024021212015439400_i2331-348X-29-1-6-b02","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/scd.12326","article-title":"Treatment of drooling with scopolamine in the pediatric ICU: a case series report","volume":"38","author":"Franco","year":"2018","journal-title":"Spec Care Dentist"},{"issue":"1","key":"2024021212015439400_i2331-348X-29-1-6-b03","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13052-022-01312-8","article-title":"Management of drooling in children with neurological disorders: an Italian Delphi consensus","volume":"48","author":"Riva","year":"2022","journal-title":"Ital J Pediar"},{"issue":"1","key":"2024021212015439400_i2331-348X-29-1-6-b04","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1136\/adc.2007.129478","article-title":"Management of drooling in children","volume":"96","author":"Fairhurst","year":"2011","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"12","key":"2024021212015439400_i2331-348X-29-1-6-b05","first-page":"1089","article-title":"Botulinum toxin injections for treatment of drooling in children with cerebral palsy: a systematic review and meta-analysis","volume":"8","author":"Hung","year":"2021","journal-title":"Children (Basel)"},{"key":"2024021212015439400_i2331-348X-29-1-6-b06","volume-title":"Pediatric and Neonatal Dosage Handbook","author":"Taketomo","year":"2022","edition":"29th ed"},{"issue":"2","key":"2024021212015439400_i2331-348X-29-1-6-b07","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/pch\/pxab051","article-title":"Anticholinergic treatment for sialorrhea in children: a systematic review","volume":"27","author":"You","year":"2021","journal-title":"Paediatr Child Health"},{"issue":"5","key":"2024021212015439400_i2331-348X-29-1-6-b08","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1590\/0004-282x20170033","article-title":"Treatment of drooling with sublingual atropine sulfate in children and adolescents with cerebral palsy","volume":"5","author":"Dias","year":"2017","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"2024021212015439400_i2331-348X-29-1-6-b09","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/ipd.12219","article-title":"Sublingual administration of atropine eyedrops in children with excessive drooling\u2014a pilot study","volume":"27","author":"Norderyd","year":"2017","journal-title":"Int J Paediatr Dent"},{"issue":"3","key":"2024021212015439400_i2331-348X-29-1-6-b10","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-0040-1708552","article-title":"Sublingual atropine sulfate use for sialorrhea in pediatric patients","volume":"9","author":"Azapagasi","year":"2020","journal-title":"J Pediatr Intensive Care"},{"issue":"1","key":"2024021212015439400_i2331-348X-29-1-6-b11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1440-1754.1997.tb00991.x","article-title":"Preliminary study of glycopyrrolate in the management of drooling","volume":"33","author":"Stern","year":"1997","journal-title":"J Paediatr Child Health"},{"issue":"8","key":"2024021212015439400_i2331-348X-29-1-6-b12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/000992289803700805","article-title":"Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy","volume":"37","author":"Bachrach","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"issue":"12","key":"2024021212015439400_i2331-348X-29-1-6-b13","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/archpedi.154.12.1214","article-title":"Treatment of sialorrhea with glycopyrrolate: a double-blind, dose ranging study","volume":"154","author":"Mier","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"key":"2024021212015439400_i2331-348X-29-1-6-b14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/TCRM.S27362","article-title":"Safety and efficacy of glycopyrrolate oral solution for management of pathologic drooling in pediatric patients with cerebral palsy and other neurologic conditions","volume":"8","author":"Zeller","year":"2012","journal-title":"Ther Clin Risk Manag"},{"key":"2024021212015439400_i2331-348X-29-1-6-b15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/s13052-021-01173-7","article-title":"Compounded glycopyrrolate is a compelling choice in drooling children: five years of facility experience","volume":"47","author":"Zanon","year":"2021","journal-title":"Ital J Pediatr"},{"issue":"1","key":"2024021212015439400_i2331-348X-29-1-6-b16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13052-021-01195-1","article-title":"Glycopyrrolate for drooling in children with medical complexity under three years of age","volume":"48","author":"Lovardi","year":"2022","journal-title":"Ital J Pediatr"},{"issue":"3","key":"2024021212015439400_i2331-348X-29-1-6-b17","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1542\/peds.2003-1104-L","article-title":"Effect of botulinum toxin in the treatment of drooling; a controlled clinical trial","volume":"114","author":"Jongerius","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"2024021212015439400_i2331-348X-29-1-6-b18","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12887-020-02336-x","article-title":"Efficacy of scopolamine transdermal patch in children with sialorrhea in a pediatric tertiary care hospital","volume":"20","author":"Al Jeraisy","year":"2020","journal-title":"BMC Pediatr"},{"issue":"3","key":"2024021212015439400_i2331-348X-29-1-6-b19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pediatrneurol.2010.09.008","article-title":"Use of trihexyphenidyl in children with cerebral palsy","volume":"44","author":"Carranza-del Rio","year":"2011","journal-title":"Pediatr Neurol"},{"issue":"4","key":"2024021212015439400_i2331-348X-29-1-6-b20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/archdischild-2017-313763","article-title":"The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability","volume":"103","author":"Parr","year":"2018","journal-title":"Arch Dis Child"},{"issue":"3","key":"2024021212015439400_i2331-348X-29-1-6-b21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/dmcn.14350","article-title":"Anticholinergic medications for reducing drooling in children with developmental disability","volume":"62","author":"Reid","year":"2020","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"2024021212015439400_i2331-348X-29-1-6-b22","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1111\/j.1469-8749.2009.03519.x","article-title":"The Drooling Impact Scale: a measure of the impact of drooling in children with developmental disabilities","volume":"52","author":"Reid","year":"2010","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"2024021212015439400_i2331-348X-29-1-6-b23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-8749.1989.tb04000.x","article-title":"Efficacy of benztropine therapy for drooling","volume":"31","author":"Camp-Bruno","year":"1989","journal-title":"Dev Med Child Neurol"},{"issue":"2","key":"2024021212015439400_i2331-348X-29-1-6-b24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF02412423","article-title":"Three treatment approaches and clinical factors in the reduction of drooling","volume":"3","author":"Thomas-Stonell","year":"1988","journal-title":"Dysphagia"},{"issue":"7","key":"2024021212015439400_i2331-348X-29-1-6-b25","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s00431-022-04460-5","article-title":"Drooling outcome measures in paediatric disability: a systematic review","volume":"181","author":"Sforza","year":"2022","journal-title":"Eur J Pediatr"},{"issue":"pt 3","key":"2024021212015439400_i2331-348X-29-1-6-b26","first-page":"233","article-title":"Transdermal scopolamine in drooling","volume":"32","author":"Brodtkorb","year":"1988","journal-title":"J Ment Defic Res"},{"issue":"4","key":"2024021212015439400_i2331-348X-29-1-6-b27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1469-8749.1980.tb04349.x","article-title":"Drool control: long-term follow-up","volume":"22","author":"Rapp","year":"1980","journal-title":"Dev Med Child Neurol"},{"issue":"11","key":"2024021212015439400_i2331-348X-29-1-6-b28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1469-8749.1990.tb08121.x","article-title":"Use of benzhexol hydrochloride to control drooling of children with cerebral palsy","volume":"32","author":"Reddihough","year":"1990","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"2024021212015439400_i2331-348X-29-1-6-b29","first-page":"258","article-title":"Pediatric pharmacokinetics","volume":"34","author":"Wagner","journal-title":"Pediatr Rev. 2013"},{"key":"2024021212015439400_i2331-348X-29-1-6-b30","author":"TRANSDERM SCOP [package insert]","year":"2013"},{"key":"2024021212015439400_i2331-348X-29-1-6-b31","unstructured":"Institute of Safe Medication Practices\n          . Analysis of transdermal medication patch errors uncovers a \u201cpatchwork\u201d of safety challenges. Accessed March 1, 2023. https:\/\/www.ismp.org\/resources\/analysis-transdermal-\u00admedication-patch-errors-uncovers-patchwork-safety-challenges"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/1\/6\/3326011\/i2331-348x-29-1-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/29\/1\/6\/3326011\/i2331-348x-29-1-6.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T18:42:04Z","timestamp":1738780924000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/29\/1\/article-p6.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,2,7]]},"published-print":{"date-parts":[[2024,2,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-29.1.6","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}